- A multinational study presented at the EADV Congress has linked GLP-1 weight loss medications, such as Ozempic and Wegovy, to unexpected side-effects affecting nails, hair, and scalps.
- Users of the drugs were found to be more than four times as likely to suffer from nail detachment compared to non-users, alongside experiencing noticeable nail discolouration.
- The research also revealed widespread scalp inflammation, hair thinning, and shedding among users, suggesting a biological response beyond standard weight-loss-related hair shedding.
- Scientists emphasised that weight loss alone could not account for these issues, though experts advise patients not to stop taking the medications without consulting a doctor.
- The findings were based on a controlled investigation of 575 patients across four countries, with long-term clinical trials now planned to monitor side-effects from the first dose.
IN FULL
Weight loss jabs linked to unusual health problem in new study
